 |
|
Incidence of Occult Bacteremia Among Highly Febrile Young Children in the Era of the Pneumococcal Conjugate Vaccine
A Study From a Children's Hospital Emergency Department and Urgent Care Center
Matthew L. Stoll, PhD, MD;
Lorry G. Rubin, MD
Arch Pediatr Adolesc Med. 2004;158:671-675.
Background The optimal diagnostic approach to and management of well-appearing, highly febrile young children has been a matter of debate owing to the possibility of clinically inapparent, or occult, bacteremia (OB). The most common causative organism of OB is Streptococcus pneumoniae. Universal immunization with a heptavalent pneumococcal conjugate vaccine (PCV7) has recently been implemented, but there are limited data on the impact of this vaccine on the incidence of OB.
Objective To evaluate the incidence of OB in the era of routine use of PCV7.
Methods We conducted a retrospective cohort study of highly febrile (temperature, 39°C) children between the ages of 2 months and 36 months who had blood cultures performed in the emergency department or urgent care center between December 11, 2001, and March 5, 2003, and were discharged to home at the time of the initial visit.
Results Of 329 blood cultures obtained from children who met inclusion criteria and did not meet exclusion criteria, 3 (0.91%; 95% confidence interval, 0%-1.9%) yielded a pathogenic bacterium; all were S pneumoniae. Neither an elevated total white blood cell count, an elevated absolute neutrophil count, nor an increased percentage of bands was highly predictive of OB. Blood cultures positive for organisms were more commonly due to contaminants (4; 95% confidence interval, 0%-2.4%) than pathogens.
Conclusions In the PCV7 era, OB is uncommon in highly febrile children 2 to 36 months of age. With continued use of PCV7, the routine practice of obtaining blood cultures and complete blood cell counts may no longer be indicated in previously healthy, well-appearing, highly febrile children 2 to 36 months of age, particularly those who have received at least 1 dose of PCV7.
From the Division of Infectious Diseases (Dr Rubin) and Department of Pediatrics (Drs Stoll and Rubin), Schneider Children's Hospital of the North Shore–Long Island Jewish Health System, Albert Einstein College of Medicine, New Hyde Park, NY.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Does This Child Have a Urinary Tract Infection?
Shaikh et al.
JAMA 2007;298:2895-2904.
ABSTRACT
| FULL TEXT
Updated Review of Blood Culture Contamination
Hall and Lyman
Clin. Microbiol. Rev. 2006;19:788-802.
ABSTRACT
| FULL TEXT
The Impact of Conjugate Pneumococcal Vaccination on Routine Childhood Vaccination and Primary Care Use in 2 Counties
Szilagyi et al.
Pediatrics 2006;118:1394-1402.
ABSTRACT
| FULL TEXT
Incidence and Predictors of Serious Bacterial Infections Among 57- to 180-Day-Old Infants
Hsiao et al.
Pediatrics 2006;117:1695-1701.
ABSTRACT
| FULL TEXT
Pneumococcal Vaccine
Barone
Arch Pediatr Adolesc Med 2005;159:91-91.
FULL TEXT
Occult Bacteremia: Risk Decreases after Pneumococcal Conjugate Vaccine
Paul
AAP Grand Rounds 2004;12:46-46.
FULL TEXT
Pneumococcal Vaccination Reduces Incidence of Occult Bacteremia in Young Children
JWatch General 2004;2004:6-6.
FULL TEXT
|
